Preclinical evaluation shows that folate receptor-α CAR T cells demonstrate significant antitumor activity against osteosarcoma, indicating potential for future therapies.
Supplementary Figure S1. Clinical characteristics of PDX specimens generously provided by the lab of Dr. E. Alejandro Sweet-Cordero at the University of California, San Francisco.
No takes yet. Share an insight, caveat, or question.
Choe et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: